Bifidobacteria support optimal infant vaccine responses/Experiment 2/Signature 2

EditHistoryDelete

Flag for review

Your review change was submitted

Reviewed Marked as Reviewed by KateRasheed on 2025-7-8

Curated date: 2025/04/15

Curator: ShadeAkinremi

Revision editor(s): ShadeAkinremi, Victoria, KateRasheed

Source: Supplementary Table 11a

Description: Differentially abundant microbial species in stool samples collected from Neo-ABX infants at week 1 compared to No-ABX infants. Only taxa detected in >5% of samples are considered for differential abundance analysis.

Abundance in Group 1: decreased abundance in Neonatal Antibotic (Neo-ABX) group [Week-1]

NCBI	Quality Control	Links
Bifidobacterium adolescentis
Bifidobacterium angulatum
Bifidobacterium pseudocatenulatum
Collinsella aerofaciens
Streptococcus sp. CCH5-D3
Collinsella sp. TF06-26
Collinsella sp. AF25-2LB

Revision editor(s): ShadeAkinremi, Victoria, KateRasheed